Humana Missed Mark On Market In Seizure Drug Suit

A California federal judge has cut antitrust claims from Humana's suit accusing Mallinckrodt of orchestrating an "outrageous" price-gouging scheme for a hormone gel after finding problems with how the insurer defined...

Already a subscriber? Click here to view full article